AffyImmune Therapeutics
Phase 1Enhancing CAR T cell therapy with noninvasive monitoring for better patient outcomes
Founded
2015
Focus
Cell & Gene Therapy
About
Enhancing CAR T cell therapy with noninvasive monitoring for better patient outcomes
Funding History
2Total raised: $47M
Series B$26MCormorant Asset ManagementMay 15, 2022
Series A$21MUndisclosedJan 15, 2020
Company Info
TypePrivate
Founded2015
LocationNatick, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile